Health

Ema, CHMP launches rolling review of Valneva Covid-19 vaccine

ADVERTISING
Rome, 3 December – Ema’s Committee for Medicinal Products for Human Use (CHMP) launches rolling review of VLA2001, anti-Covid 19 vaccine developed by Valneva.

ADVERTISING

ADVERTISING
1 of 6